Wintest
6721
Osaka Yuka Industry
4124
D. Western Therapeutics Institute
4576
Asiro
7378
Hamee
3134
(Q1)Jun 30, 2020 | (FY)Mar 31, 2020 | (FY)Mar 31, 2019 | |
---|---|---|---|
Assets | |||
Current assets | |||
Cash, cash equivalents and short term investments | --266.44B | -14.91%219.66B | --258.16B |
-Cash and cash equivalents | --264.05B | -15.55%217.1B | --257.07B |
-Short term investments | --2.39B | 134.34%2.57B | --1.1B |
Receivables | --191.54B | 20.83%192.8B | --159.56B |
-Accounts receivable | --191.54B | 20.83%192.8B | --159.56B |
Inventory | --244.98B | -5.53%215.11B | --227.7B |
Other current assets | --49.08B | 12.13%43.17B | --38.5B |
Total current assets | --752.04B | -1.93%670.73B | --683.92B |
Non current assets | |||
Net PPE | --1.2T | -7.47%1.23T | --1.33T |
-Gross PP&E | --1.2T | -7.47%1.23T | --1.33T |
Total investment | --35.23B | -12.52%30.64B | --35.02B |
-Long-term equity investment | --6.09B | 6.72%6.08B | --5.7B |
-Financial asset investment | --29.14B | -16.26%24.56B | --29.32B |
-Including:Available-for-sale securities | --29.14B | -16.26%24.56B | --29.32B |
Goodwill and other intangible assets | --515.22B | -10.34%530.42B | --591.57B |
-Goodwill | --384.65B | -0.82%384.65B | --387.82B |
-Other intangible assets | --130.57B | -28.46%145.77B | --203.75B |
Deferred tax assets-non current | --255.93B | 44.17%256.96B | --178.23B |
Other non current assets | --3.51B | -43.98%3.59B | --6.41B |
Total non current assets | --2.01T | -4.15%2.05T | --2.14T |
Total assets | --2.76T | -3.61%2.72T | --2.82T |
Liabilities | |||
Current liabilities | |||
Financial liabilities | --151.09B | 106.82%140.04B | --67.71B |
-Current debt and capital lease obligation | --148.95B | 128.45%138.37B | --60.57B |
-Including:Current debt | --122.64B | 169.02%111.68B | --41.51B |
-Including:Current capital Lease obligation | --26.31B | 40.06%26.69B | --19.06B |
-Other financial liabilities | --2.13B | -76.67%1.67B | --7.14B |
Payables | --363.43B | -31.41%320.18B | --466.79B |
-accounts payable | --361.99B | -31.73%317.81B | --465.5B |
-Total tax payable | --1.44B | 83.22%2.37B | --1.29B |
Current provisions | --4.27B | -53.72%3.73B | --8.05B |
Other current liabilities | --39.09B | 14.86%43B | --37.44B |
Current liabilities | --557.87B | -12.60%506.94B | --579.99B |
Non current liabilities | |||
Non current financial liabilities | --1.43T | 9.74%1.44T | --1.32T |
-Long term debt and capital lease obligation | --1.12T | 47.51%1.14T | --770.13B |
-Including:Long term debt | --1T | 49.09%1.01T | --680.24B |
-Including:Long term capital lease obligation | --118.24B | 35.61%121.9B | --89.89B |
-Other financial liabilities-Non current | --311.64B | -43.54%308.3B | --546.04B |
Long term provisions | --5.12B | 13.05%4.43B | --3.92B |
Long term pension and other post-retirement benefit plans | --47.73B | -4.37%47.23B | --49.38B |
Non current deferred liabilities | --31M | -61.03%53M | --136M |
Other non current liabilities | --15.85B | 535.53%16.12B | --2.54B |
Total non current liabilities | --1.5T | 10.21%1.51T | --1.37T |
Total liabilities | --2.06T | 3.43%2.02T | --1.95T |
Shareholders'equity | |||
Share capital | --10B | 0.00%10B | --10B |
-common stock | --10B | 0.00%10B | --10B |
Additional paid-in capital | --851.52B | 0.14%851.52B | --850.35B |
Retained earnings | ---154.66B | -1,908.21%-156.36B | --8.65B |
Other equity interest | ---2.85B | -111.99%-6.01B | ---2.84B |
Total stockholders'equity | --704.01B | -19.28%699.15B | --866.16B |
Noncontrolling interests | --87M | -95.32%90M | --1.92B |
Total equity | --704.1B | -19.45%699.24B | --868.08B |
Currency Unit | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |